Related Experiment Video
Updated: Aug 13, 2026

Assessment of Lymphocyte Migration in an Ex Vivo Transmigration System
Published on: September 20, 2019
Polymorphisms within the CTLA4 gene are associated with infant atopic dermatitis
1Institute for Immunology and Allergy Research (Westmead Millennium Institute), University of Sydney, Westmead Hospital, Australia. graham_jones@wmi.usyd.edu.au
Insights
Genetic variations in the CTLA4 gene are linked to early-onset atopic dermatitis (AD) in children. The +49(A)/CT60(A) haplotype appears to be a shared genetic risk factor for both AD and asthma.
Area of Science:
- Immunogenetics
- Pediatric Dermatology
- Allergy Research
Background:
- Atopic dermatitis (AD) is a prevalent childhood skin disorder with significant physical and psychological impacts.
- While environmental factors play a role, AD has a strong genetic basis, potentially linked to other allergic conditions like asthma.
Purpose of the Study:
- To investigate the association between polymorphisms in the cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene and early-onset childhood atopic dermatitis (AD).
- CTLA4 is a key regulator of T-cell activity and has been previously linked to asthma and autoimmune diseases.
Main Methods:
- A family-based cohort of 112 children diagnosed with AD within the first three years of life was studied in Western Sydney, Australia.
- The transmission disequilibrium test was employed to assess associations of the +49 and CT60 polymorphisms in the CTLA4 gene.
Main Results:
- The +49(A) allele showed a significant association with AD (P = 0.037).
- The CT60(A) allele displayed borderline significance (P = 0.055).
- A significant association was found for the combined +49(A)/CT60(A) haplotype (P = 0.002), indicating a shared genetic risk factor.
Conclusions:
- Polymorphisms in the CTLA4 gene are associated with early-onset infant atopic dermatitis.
- The findings suggest that the +49(A)/CT60(A) CTLA4 haplotype is a common genetic risk factor for both atopic dermatitis and asthma.
Background:
Atopic dermatitis (AD) is one of the most common childhood disorders. It can have a significant impact on the physical and psychological well-being of affected individuals. Although environmental triggers are important, AD also has a strong genetic component. Identifying genes associated with AD may help to understand better the basis of this disorder and its relationship with other allergic disorders such as asthma.
Objectives:
Polymorphisms in the gene encoding the inhibitory CTLA4 receptor, an important regulator of T cells, are associated with asthma as well as autoimmune disorders. We have now tested whether polymorphisms in the CTLA4 gene are also associated with early childhood AD.
Methods:
A family-based cohort of 112 children and their parents was recruited from Western Sydney, Australia. All children were seen by a paediatric dermatologist and presented with AD within the first 3 years of life. Using the transmission disequilibrium test, individual and haplotypic associations with the +49 and CT60 polymorphisms in exon 1 and the 3' nontranslated DNA of the CTLA4 gene were tested.
Results:
Single tests of association revealed significant association of the +49(A) [P = 0.037, odds ratio (OR) 1.59, 95% confidence interval (CI) 1-2.55] and borderline significance of the CT60(A) alleles (P = 0.055, OR 1.51, 95% CI 1-2.38). Significant association of the +49(A)/CT60(A) haplotype was detected (P = 0.002, OR 1.78, 95% CI 1.2-2.65).
Conclusions:
Polymorphisms within the gene encoding CTLA4 were associated with early onset infant AD. This is in agreement with findings from asthmatic cohorts, suggesting that the +49(A)/CT60(A) haplotype is a genetic risk factor common to asthma and AD.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Pleiotropy
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Inflammatory Bowel Disease III: Crohn's Disease
Epistasis
